Arcus agrees to buy SK Pharma from Syz Capital and Saturnus Capital
Thursday, October 1, 2026 · first reported by PE Hub
Arcus acquires SK Pharma, a Bielefeld-based operator of eight temperature-controlled pharmaceutical warehouses in northwest Germany, from sponsors Syz Capital and Saturnus Capital.
- Firm
- Arcus
- Also named
- SK Pharma, Syz Capital, Saturnus Capital
- Asset class
- Private equity
- Geography
- Europe
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore in Deals
From the same day- Antin agrees sale of majority stake in Vicinity Energy to Harrison StreetPrivate Equity Wire +1
- Sycamore nears $9bn sale of Boots to Weston familyPrivate Equity Wire
- CPP Investments sells A$4.5bn Australian toll road stakes to TransurbanIPE Real Assets
- AEW JV buys stake in Texas mall for $194.3mPERE
- CSC acquires 50% Watergardens mall stake from QIC for A$480mIPE Real Assets
- Lone Star buys €216m Dutch residential portfolio from Catella fundIPE Real Assets